This issue of Otolaryngologic Clinics, guest edited by Drs. Sarah K. Wise, Ashkan Monfared, and Nicole C. Schmitt is devoted to Biologics in Otolaryngology. This issue is one of six selected each year by our series consulting editor, Dr. Sujana S. Chandrasekhar. Articles in this issue include: Biologics in otolaryngology overview, Current evidence for biologic therapy in chronic rhinosinusitis with nasal polyposis, Choosing the right patient for biologic therapy in CRSwNP, Knowledge gaps and research needs for biologic therapy in rhinology practice, Mechanisms and practical use of biologic therapies for allergy and asthma indications, Immunotherapeutic strategies in head and neck cancer, Cetuximab in head and neck cancer, Anti-PD-1 immune checkpoint blockade for head and neck cancer, Advances in adoptive cell therapy for head and neck cancer, Biologics for the treatment of recurrent respiratory papillomatosis, Past and future biologics for otologic disorders, Biological treatments for Neurofibromatosis Type II and other skullbase disorders, and Biologics in treatment of autoimmune ear disorders.
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
Biologics in Otolaryngology: Past, Present, and FutureCurrent Evidence for Biologic Therapy in Chronic Rhinosinusitis with Nasal Polyposis
Choosing the Right Patient for Biologic Therapy in Chronic Rhinosinusitis with Nasal Polyposis: Endotypes, Patient Characteristics, and Defining Failures of Standard Therapy
Knowledge Gaps and Research Needs for Biologic Therapy in Rhinology Practice
Mechanisms and Practical Use of Biologic Therapies for Allergy and Asthma Indications
Immunotherapeutic Strategies for Head and Neck Cancer
Epidermal Growth Factor Receptor-Targeted Therapy for Head and Neck Cancer
Anti-PD-1 Immune Checkpoint Blockade for Head and Neck Cancer: Biomarkers of Response and Resistance
Advances in Adoptive Cell Therapy for Head and Neck Cancer
Biologics for the Treatment of Recurrent Respiratory Papillomatosis
Past and Future Biologics for Otologic Disorders
Biological Treatments of Neurofibromatosis Type 2 and Other Skull Base Disorders
Biologics for Immune-Mediated Sensorineural Hearing Loss
Women in Academic Medicine and Leadership
Balance Versus Integration: Work-Life Considerations
Authors
Sarah K. Wise ProfessorDepartment of Otolaryngology-Head and Neck
Emory University
Atlanta, GA, USA. Ashkan Monfared Directory of Otology and Neurotology
The George Washington Medical Faculty Associates
Washington, DC, USA. Nicole Schmitt Department of Otolaryngology-Head and Neck Surgery, Emory University.
